Net Cash Provided by (Used in) Operating Activities in USD of RVL Pharmaceuticals plc from 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
RVL Pharmaceuticals plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2017 to Q1 2023.
  • RVL Pharmaceuticals plc Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2023 was -$5.82M, a 56.2% increase year-over-year.
  • RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$37.8M, a 30.9% increase from 2021.
  • RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$54.7M, a 411% decline from 2020.
  • RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Operating Activities for 2020 was $17.6M, a 47.6% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

RVL Pharmaceuticals plc Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$5.82M +$7.46M +56.2% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q1 2022 -$13.3M -$1.79M -15.6% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q1 2021 -$11.5M -$11.4M -17847% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q1 2020 -$64K +$6.06M +99% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q1 2019 -$6.13M -$13.2M -186% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q1 2018 $7.1M 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019

RVL Pharmaceuticals plc Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$37.8M +$16.9M +30.9% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2023
2021 -$54.7M -$72.3M -411% 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2023
2020 $17.6M -$16M -47.6% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 $33.6M -$3.99M -10.6% 01 Jan 2019 31 Dec 2019 8-K 08 Sep 2021
2018 $37.6M -$20.3M -35.1% 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020
2017 $57.8M 01 Jan 2017 31 Dec 2017 8-K 20 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.